Rayno Life Science Stocks: ALXN, BIIB, GILD, REGN, RHHBY Update 1
Update 12:40p NASDAQ Up 2% Cardiovascular Sciences (CSII $33.90) Up 15 %-Beats on Revenues and EPS. Q2 Revenues up 28% to $32.3M. Net Loss was $8.7M compared to $5.8M in 2013 fiscal Q2. Thermo Fisher (TMO $114) up 2.4% on 10% 2013 EPS gain. Q4 revenues up 6% to $3.47B. All Rayno stocks are...
Sidebar To Cult Momentum Stocks: AMZN, NFLX, TSLA, TWTR
Update 2/3/14 NetLaZon=$927 vs $979 down 5.3% since 1/29/14 =NFLX+TSLA+AMZN Momentum Still Rules With not much to say about biotech today except it appears unfazed by macro news (see BIIB $316 up 4%, MDVN $85 up 12%, ILMN $150 up 3.4%). Today I'll delve into the media stars outside of...
Biotech Stocks Recover From 5 Day 5% Sell-Off
Plenty Of FirePower Left In Biotech-IBB Up 2.2% At $244 Biotechnology stocks have been quite volatile and not immune to downdrafts but today they made an impressive recovery. Nonetheless I would be selective and not trade the small cap high fliers unless you did your homework and trading is...
Speculative Fever Broken In Biotech But Sector Still Up 5% YTD
Follow Technical Levels -Avoid High Flyers Five Trends To Watch In Biotech-Preliminary Model Large Cap Biopharmaceuticals: metrics already reviewed-awaiting 2013 financial reporting. Key Technicals on Market indices: IBB,XBI,PBE, FBIOX, QQQ. Mid-Cap Emerging Growth in Immuno-Oncology: Stocks...
Biotech Sell-Off Down 1%+: Was Goldman Call Right? Update 1/24 2:20p
Update 1/24 With 2 hrs Trading to go.....Technical levels holding with sector up 7-8% YTD. NASDAQ still falling down 1.9% at 4139, QQQ down 1.5% Given the huge 11% move through the J.P.Morgan Conference in January we should only look at technical levels until earnings cycle is completed: ETFs...